17:32 EDT Avid Bioservices still sees FY24 revenue $137M-$147M, consensus $138.66M
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDMO:
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
- Avid Bioservices management to meet with Craig Hallum
- Avid Bioservices announces receipt of deficiency notice from Nasdaq
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
- Avid Bioservices to delay 10-Q filing, must restate Q3 financials
